DK1631275T3 - Behandling og forebyggelse af excessiv ardannelse med 4-hydroxy-tamoxifen - Google Patents
Behandling og forebyggelse af excessiv ardannelse med 4-hydroxy-tamoxifenInfo
- Publication number
- DK1631275T3 DK1631275T3 DK04740032T DK04740032T DK1631275T3 DK 1631275 T3 DK1631275 T3 DK 1631275T3 DK 04740032 T DK04740032 T DK 04740032T DK 04740032 T DK04740032 T DK 04740032T DK 1631275 T3 DK1631275 T3 DK 1631275T3
- Authority
- DK
- Denmark
- Prior art keywords
- excessive scarring
- tamoxifen
- hydroxy
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47661803P | 2003-06-09 | 2003-06-09 | |
| PCT/EP2004/006583 WO2004110420A1 (en) | 2003-06-09 | 2004-06-02 | Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1631275T3 true DK1631275T3 (da) | 2008-08-18 |
Family
ID=33551623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04740032T DK1631275T3 (da) | 2003-06-09 | 2004-06-02 | Behandling og forebyggelse af excessiv ardannelse med 4-hydroxy-tamoxifen |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7767717B2 (da) |
| EP (1) | EP1631275B1 (da) |
| JP (1) | JP4682129B2 (da) |
| AT (1) | ATE393625T1 (da) |
| AU (1) | AU2004246812B8 (da) |
| CA (1) | CA2528431C (da) |
| DE (1) | DE602004013439T2 (da) |
| DK (1) | DK1631275T3 (da) |
| ES (1) | ES2304610T3 (da) |
| HK (1) | HK1082203A1 (da) |
| NZ (1) | NZ544031A (da) |
| PT (1) | PT1631275E (da) |
| WO (1) | WO2004110420A1 (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003294973B2 (en) * | 2002-12-18 | 2010-05-13 | Besins Healthcare Luxembourg Sarl | Prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
| DE60327363D1 (de) | 2002-12-18 | 2009-06-04 | Besins Int Lab | Verringerung der dichte des brustgewebes durch 4-hydroxy tamoxifen |
| AU2003303033B2 (en) * | 2002-12-18 | 2009-06-04 | Besins Healthcare Luxembourg Sarl | Treatment of mastalgia with 4-hydroxy tamoxifen |
| DK1694319T3 (da) * | 2003-12-15 | 2008-11-17 | Besins Int Lab | Anvendelser af 4-hydroxytamoxifen til fremstilling af et medikament til behandling af gynækomasti |
| US7968532B2 (en) | 2003-12-15 | 2011-06-28 | Besins Healthcare Luxembourg | Treatment of gynecomastia with 4-hydroxy tamoxifen |
| US7507769B2 (en) | 2004-03-22 | 2009-03-24 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| EP1579857A1 (en) * | 2004-03-22 | 2005-09-28 | Laboratoires Besins International | Chemically stable compositions of 4-hydroxy tamoxifen |
| EP1647271A1 (en) * | 2004-10-14 | 2006-04-19 | Laboratoires Besins International | 4-Hydroxy tamoxifen gel formulations |
| EP1891945A1 (en) * | 2006-07-31 | 2008-02-27 | Laboratoires Besins International | Treatment and prevention of excessive scarring |
| CA2659344C (en) * | 2006-07-31 | 2015-03-17 | Laboratoires Besins International | Treatment and prevention of excessive scarring |
| US20130184220A1 (en) * | 2007-12-21 | 2013-07-18 | Bradford James Duft | Treatment of abnormal or excessive scars |
| AU2008343758A1 (en) * | 2007-12-21 | 2009-07-09 | Coda Therapeutics, Inc. | Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars |
| US20140350117A1 (en) * | 2013-05-22 | 2014-11-27 | Professional Compounding Centers Of America | Topical Scar Treatment Composition and Method of Using Same |
| US20140350106A1 (en) * | 2013-05-22 | 2014-11-27 | Professional Compounding Centers Of America | Urea Silicone Gel for Scars and Hydration Treatment and Method of Using Same |
| CA3074440A1 (en) * | 2017-09-01 | 2019-03-07 | Excel Med, Llc | Pharmaceutical composition for treating keloid and uses thereof |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2558373B1 (fr) * | 1984-01-20 | 1987-07-03 | Mauvais Jarvis Pierre | Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee |
| ATE80152T1 (de) | 1987-04-21 | 1992-09-15 | Heumann Pharma Gmbh & Co | Stabile loesungsmitteladdukte von z-1-(p-betadimethylamino-ethoxyphenyl)-1-(p-hydroxyphenyl) 2-phenylbut-1-en. |
| US5045553A (en) | 1987-06-24 | 1991-09-03 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter |
| DE3836862A1 (de) | 1988-10-27 | 1990-05-03 | Schering Ag | Mittel zur transdermalen applikation von steroidhormonen |
| WO1991001624A2 (en) * | 1989-07-31 | 1991-02-21 | Massachusetts Institute Of Technology | Use of calcium antagonists for treating scars |
| TW218849B (da) | 1991-05-17 | 1994-01-11 | Bristol Myers Squibb Co | |
| DE69334068D1 (de) | 1992-07-20 | 2006-11-16 | Massachusetts Inst Technology | Kontrolle der wundvernarbung mit calmodulin-inhibitoren oder protein-kinase-c-inhibitoren |
| US5552162A (en) | 1993-02-09 | 1996-09-03 | Arch Development Corporation | Method for improvement of scar size and appearance |
| US5613958A (en) | 1993-05-12 | 1997-03-25 | Pp Holdings Inc. | Transdermal delivery systems for the modulated administration of drugs |
| US5720963A (en) | 1994-08-26 | 1998-02-24 | Mary Kay Inc. | Barrier disruption treatments for structurally deteriorated skin |
| JP2001527037A (ja) * | 1997-12-23 | 2001-12-25 | ヘキサル アーゲー | Ｚ−４−ヒドロキシタモキシフェン及びシクロデキストリンを含む混合物及び薬剤学的組成 |
| US6013270A (en) | 1998-04-20 | 2000-01-11 | The Procter & Gamble Company | Skin care kit |
| DE10033853A1 (de) | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| ES2330188T3 (es) | 2001-12-07 | 2009-12-07 | Besins Manufacturing Belgium | Composicion farmaceutica en forma de gel o de solucion a base de dihidrotestoterona, su procedimiento de preparacion y sus utilizaciones. |
| AU2003303033B2 (en) | 2002-12-18 | 2009-06-04 | Besins Healthcare Luxembourg Sarl | Treatment of mastalgia with 4-hydroxy tamoxifen |
| AU2003294973B2 (en) | 2002-12-18 | 2010-05-13 | Besins Healthcare Luxembourg Sarl | Prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
| DE60327363D1 (de) | 2002-12-18 | 2009-06-04 | Besins Int Lab | Verringerung der dichte des brustgewebes durch 4-hydroxy tamoxifen |
| US7968532B2 (en) | 2003-12-15 | 2011-06-28 | Besins Healthcare Luxembourg | Treatment of gynecomastia with 4-hydroxy tamoxifen |
| EP1579856A1 (en) | 2004-03-22 | 2005-09-28 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| US7507769B2 (en) | 2004-03-22 | 2009-03-24 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| EP1579857A1 (en) | 2004-03-22 | 2005-09-28 | Laboratoires Besins International | Chemically stable compositions of 4-hydroxy tamoxifen |
| EP1647271A1 (en) | 2004-10-14 | 2006-04-19 | Laboratoires Besins International | 4-Hydroxy tamoxifen gel formulations |
-
2004
- 2004-06-02 CA CA2528431A patent/CA2528431C/en not_active Expired - Lifetime
- 2004-06-02 US US10/858,399 patent/US7767717B2/en active Active
- 2004-06-02 DE DE602004013439T patent/DE602004013439T2/de not_active Expired - Lifetime
- 2004-06-02 ES ES04740032T patent/ES2304610T3/es not_active Expired - Lifetime
- 2004-06-02 WO PCT/EP2004/006583 patent/WO2004110420A1/en active IP Right Grant
- 2004-06-02 AU AU2004246812A patent/AU2004246812B8/en not_active Expired
- 2004-06-02 EP EP04740032A patent/EP1631275B1/en not_active Expired - Lifetime
- 2004-06-02 JP JP2006515986A patent/JP4682129B2/ja not_active Expired - Lifetime
- 2004-06-02 DK DK04740032T patent/DK1631275T3/da active
- 2004-06-02 PT PT04740032T patent/PT1631275E/pt unknown
- 2004-06-02 AT AT04740032T patent/ATE393625T1/de active
- 2004-06-02 NZ NZ544031A patent/NZ544031A/en unknown
-
2006
- 2006-03-22 HK HK06103609A patent/HK1082203A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2304610T3 (es) | 2008-10-16 |
| HK1082203A1 (en) | 2006-06-02 |
| CA2528431C (en) | 2012-09-18 |
| CA2528431A1 (en) | 2004-12-23 |
| WO2004110420A8 (en) | 2005-11-24 |
| EP1631275A1 (en) | 2006-03-08 |
| AU2004246812A1 (en) | 2004-12-23 |
| DE602004013439T2 (de) | 2009-06-04 |
| US7767717B2 (en) | 2010-08-03 |
| EP1631275B1 (en) | 2008-04-30 |
| AU2004246812B2 (en) | 2009-12-17 |
| AU2004246812B8 (en) | 2010-01-14 |
| DE602004013439D1 (de) | 2008-06-12 |
| WO2004110420A1 (en) | 2004-12-23 |
| US20050032910A1 (en) | 2005-02-10 |
| NZ544031A (en) | 2008-08-29 |
| JP4682129B2 (ja) | 2011-05-11 |
| PT1631275E (pt) | 2008-08-04 |
| JP2006527234A (ja) | 2006-11-30 |
| ATE393625T1 (de) | 2008-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1082203A1 (en) | Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen | |
| ATE551996T1 (de) | Behandlung oder prävention von diabetes mit cannabidiol | |
| BRPI0510925A (pt) | métodos e composições para cicatrização de ferida | |
| DK1545587T3 (da) | Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår | |
| EA200802213A1 (ru) | Способы лечения заболеваний крови | |
| ATE526959T1 (de) | Behandlung von muskelschwund mit selektiven androgenrezeptormodulatoren | |
| EA202192122A1 (ru) | Соединения, обладающие активностью индуцирования ферроптоза, и способы их применения | |
| CY1106026T1 (el) | Αρυλσουλφοναμιδια ως ανταγωνιστες της σepοτονινης για την αγωγη της παχυσαρκιας | |
| PT1492561E (pt) | Metodo para tratar disturbios da glandula mamaria | |
| EA200970529A1 (ru) | Антивирусная композиция и способ ее применения | |
| CY1113959T1 (el) | Χρηση λιποσωματων pvp-ιωδιου για θεραπεια ακμης | |
| CY1110538T1 (el) | S-μιρταζαπινη για τη θεραπεια των εξαψεων | |
| DK1438034T3 (da) | Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens | |
| SE0200198D0 (sv) | New use | |
| DK1596879T3 (da) | Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis | |
| BR0317491A (pt) | Método de usar um inibidor de cox-2 e um inibidor de topoisomerase ii como uma terapia de combinação no tratamento de neoplasia | |
| DK1455770T3 (da) | Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser | |
| ATE314066T1 (de) | Verwendung von buprenorphin zur therapie der harninkontinenz | |
| ATE315387T1 (de) | Verwendung von substituierten 6- dimethylaminomethyl-1-phenyl- cyclohexanverbindungen zur therapie der harninkontinenz | |
| EA200601853A1 (ru) | Лечение нарушенной дыхательной функции | |
| DK1819354T3 (da) | Fremgangsmåder og forbindelser til behandling af diabetes | |
| DK1523985T3 (da) | Ikke-radioaktivt strontiumholdigt middel til behandling af kræft | |
| ATE486594T1 (de) | Methode zur behandlung von herzinsuffizienz | |
| DE60326348D1 (de) | Makrozyclen zur behandlung von krebserkrankungen | |
| ATE288263T1 (de) | Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis) |